Amber Dance
Freelance science journalist
Freelance science journalist
Amber Dance, Ph.D., an award-winning freelance science journalist based in Southern California, co-authors the Center's Health Divide column. She also contributes to publications including PNAS Front Matter, The Scientist, and Nature. She also edits books on a variety of topics.
After earning a doctorate in biology, Amber Dance re-trained in journalism as a way to engage her broad interest in science and share her enthusiasm with readers. She mainly writes about life sciences, with particular expertise in microbiology, cell biology, neuroscience and lab techniques.
Also, a look at how COVID aid slashed poverty rates, and dozens charged in pandemic fraud case.
Also, Texas researchers report progress on variant-proof vaccine that could help quell the constant race for new boosters.
Also, a new study finds stress and depression are linked to long COVID.
The FDA and CDC have signed off on new mRNA boosters for ages 12 and up, setting the stage for a fall vaccine push to counter an anticipated fall and winter surge.
Both Moderna and Pfizer have applied for emergency authorization of their new vaccine formulas targeting both the original strain and the omicron BA.4/5 variant.
The White House promises new boosters by September, pending approvals by the CDC and FDA.
Also, disparities in booster access spell trouble for fall booster campaigns.
Also, Biden extends pandemic rescue funds for affordable housing, while a White House summit plans for future COVID vaccines.
Marginalized children missing out on vaccines in Sunshine State; mask mandates become a local issue; and yes, the COVID vaccine could affect your period.
Meanwhile, school lockdowns reversed progress for Latino education, and the wait for Novavax is nearly over.